Healthcare - Biotechnology - NASDAQ - US
$ 44.5
-3.8 %
$ 2.12 B
Market Cap
-19.26
P/E
Price Target
Average
22.10%
Revenue Forecast
Estimate
49.05%
EBIT
Estimate
--7.44%
Net Income
Estimate
34.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Mirum Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for MIRM of $54.3 , with forecasts ranging from a low of $39 to a high of $70 .
MIRM Lowest Price Target
Wall Street Target
39 USD
-12.36%
MIRM Average Price Target
Wall Street Target
54.3 USD
22.10%
MIRM Highest Price Target
Wall Street Target
70 USD
57.30%
REVENUE FORECAST
Revenue Forecast Chart MIRM
EBIT FORECAST
EBIT Forecast Chart MIRM
NET INCOME FORECAST
Net Income Chart MIRM